SCHEMBL2153604

SCHEMBL2153604

N#C[B-](C#N)(C#N)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
ALDH1A1 P00352 4/20 0.37
TRPA1 O75762 1/20 0.33
NOTUM Q6P988 1/20 0.32
CYP1A1 P04798 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP1B1 Q16678 1/20 0.32
APP P05067 1/20 0.32
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
ERBB2 P04626 1/20 0.31
KDM4E B2RXH2 2/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL15363722 0.97 TSHR (0.39) TSHRALDH1A1TRPA1NOTUMCYP1A1
Tetrylammonium SCHEMBL14637614 0.82 NPSR1 (0.39) TSHRALDH1A1CYP1A2ADORA2AADORA1
SCHEMBL15363655 0.81 CHRM4 (0.32)
SCHEMBL2769206 0.77 TSHR (0.41) TSHRALDH1A1TRPA1NOTUMCYP1A1
SCHEMBL2769209 0.74 TSHR (0.39) TSHRALDH1A1TRPA1NOTUMCYP1A1
SCHEMBL14118424 0.72 KDM4E (0.33) ALDH1A1ADORA2AADORA1ERBB2KDM4E
SCHEMBL14118169 0.72 TSHR (0.38) TSHRALDH1A1TRPA1NOTUMCYP1A1
SCHEMBL14118873 0.72 TSHR (0.38) TSHRALDH1A1TRPA1NOTUMCYP1A1
SCHEMBL14118252 0.70 TSHR (0.36) TSHRALDH1A1TRPA1
SCHEMBL14118525 0.70 TSHR (0.36) TSHRALDH1A1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9175021-B2 Process for the preparation of perfluoroalkylcyano- or perfluoroalkylcyanofluoroborates MERCK PATENT GMBH (DE) 2015-11-03 US disclosed
US-9175021-B2 Process for the preparation of perfluoroalkylcyano- or perfluoroalkylcyanofluoroborates MERCK PATENT GMBH (DE) 2015-11-03 US disclosed
US-20150166588-A1 PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2015-06-18 US disclosed
US-20150166588-A1 PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2015-06-18 US disclosed
EP-2526105-B1 ELECTROLYTE FORMULATIONS MERCK PATENT GMBH (DE) 2015-06-03 EP disclosed
US-8927757-B2 Process for the preparation of perfluoroalkylcyano- or perfluoroalkylcyanofluoroborates MERCK PATENT GMBH (DE) 2015-01-06 US disclosed
US-8927757-B2 Process for the preparation of perfluoroalkylcyano- or perfluoroalkylcyanofluoroborates MERCK PATENT GMBH (DE) 2015-01-06 US disclosed
US-8835667-B2 Electrolyte formulations MERCK PATENT GMBH (DE) 2014-09-16 US disclosed
US-20120309981-A1 PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-12-06 US disclosed
US-20120309982-A1 ELECTROLYTE FORMULATIONS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-12-06 US disclosed
US-20120309981-A1 PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-12-06 US disclosed
EP-2526107-A1 METHOD FOR PRODUCING PERFLUOROALKYL CYANOBORATES OR PERFLUOROALKYL CYANOFLUOROBORATES Merck Patent GmbH (DE) 2012-11-28 EP disclosed
WO-2011085965-A1 ELECTROLYTE FORMULATIONS MERCK PATENT GMBH (DE) 2011-07-21 WO disclosed
WO-2011085966-A1 METHOD FOR PRODUCING PERFLUOROALKYL CYANOBORATES OR PERFLUOROALKYL CYANOFLUOROBORATES MERCK PATENT GMBH (DE) 2011-07-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120309982-A1 ELECTROLYTE FORMULATIONS SLC9A5, NHERF1, AFF1 TSHR 1226/4885ALDH1A1 676/4885TRPA1 294/4885
US-20120309981-A1 PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES SLCO4C1, SLCO2B1, PFAS TSHR 731/4885ALDH1A1 4109/4885TRPA1 891/4885
US-20150166588-A1 PROCESS FOR THE PREPARATION OF PERFLUOROALKYLCYANO- OR PERFLUOROALKYLCYANOFLUOROBORATES SLCO4C1, SLCO2B1, PFAS TSHR 731/4885ALDH1A1 4109/4885TRPA1 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.